Skip to content
Screener

Kestra Medical Technologies KMTS Q1 2027 earnings

Reported September 14, 2026 · After market close

Revenue$31.0MBeat by $2.0M
EPS-$0.75Miss by $0.13
Revenue estimate$29.0M
EPS estimate-$0.62
“Kestra delivered another strong quarter of financial performance, generating revenue growth of 60% while expanding gross margin to over 56%. We remain confident that our focus on innovation and commercial expansion positions Kestra to generate durable, top-tier growth for years to come. Our team is executing on its commitments to prescribers and their patients and we believe this will continue to drive market expansion and advance Kestra on its path to market leadership.”
Brian Webster

Next report

Dec 10, 2026 (in 2 months)
Revenue estimate$32.0M
EPS estimate-$0.61

Financials

Q1 2027

Income statement

See full
Revenue$31.0M+59.9%
Gross profit$17.5M+97.7%
Operating income-$37.7M-30.4%
Net income-$44.1M-70.7%
EPS (diluted)-$0.75-50.0%

Balance sheet

See full
Cash & equivalents$68.6M-65.9%
Total debt$76.4M+71.4%
Total assets$347.4M+30.4%

Cash flow

See full
Operating cash flow-$32.3M-22.9%
CapEx$8.3M+2.1%
Free cash flow-$40.6M-18.0%

Valuation & ratios

Valuation

as of 10/02/26
See full
Market cap$1.62B+28.9%
Enterprise value$1.62B+48.0%
P/S15.1×-3.7×

Profitability

See full
Gross margin53.9%+10.4pp
Operating margin-134.5%-25.6pp
Net margin-140.4%-25.4pp
FCF margin-115%-27.1pp

Returns & leverage

See full
Current ratio4.7×-2.2×

FAQ

When did Kestra Medical Technologies report Q1 2027 earnings?
Kestra Medical Technologies (KMTS) reported Q1 2027 earnings on September 14, 2026 after market close.
What were Kestra Medical Technologies's Q1 2027 revenue and EPS?
Kestra Medical Technologies reported revenue of $31.0M and eps of $-0.75 for Q1 2027.
Did Kestra Medical Technologies beat estimates in Q1 2027?
Revenue beat the consensus estimate of $29.0M by $2.0M. EPS missed the consensus estimate of $-0.62 by $0.13.
How did Kestra Medical Technologies's Q1 2027 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 59.9% from $19.4M a year earlier and eps declined 63.0% from $-0.46.
Where can I find Kestra Medical Technologies's Q1 2027 SEC filings?
You can read the 8-K earnings release (0001193125-26-390535) and the 10-Q periodic report (0001193125-26-390766) directly on SEC EDGAR. The filing index links above go to sec.gov.